WallStreetZenWallStreetZen

NASDAQ: CYTO
Altamira Therapeutics Ltd Stock Ownership - Who owns Altamira Therapeutics?

Insider buying vs selling

Have Altamira Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CYTO insiders and whales buy or sell their stock.

CYTO Shareholders

What type of owners hold Altamira Therapeutics Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ubs Group Ag0.46%6,814$12.47kInstitution
Tower Research Capital LLC Trc0.06%851$1.56kInstitution
Group One Trading LP0.00%14$25.62Institution
Wells Fargo Company0.00%1$1.83Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

CYTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTO0.52%0.00%
NBY1.80%98.20%
QNRX0.00%100.00%
DRMA4.01%95.99%
CNSP2.97%5.30%Net BuyingNet Buying

Altamira Therapeutics Stock Ownership FAQ

Who owns Altamira Therapeutics?

Altamira Therapeutics (NASDAQ: CYTO) is owned by 0.52% institutional shareholders, 0.00% Altamira Therapeutics insiders, and 99.48% retail investors. Ubs Group Ag is the largest individual Altamira Therapeutics shareholder, owning 6814.00 shares representing 0.46% of the company. Ubs Group Ag's Altamira Therapeutics shares are currently valued at $12.47k.

If you're new to stock investing, here's how to buy Altamira Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.